“Analysis of the VCD protocol (bortezomib, cyclophosphamide, and dexamethasone) in the treatment of multiple myeloma”, RSD, vol. 12, no. 13, p. e42121344144, Nov. 2023, doi: 10.33448/rsd-v12i13.44144.